Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, dated August 22, 2024, reports a specific transaction in the company's own shares. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements (VMS).
Key Financial Metrics and Transaction Details
The filing details a share buyback transaction executed under the programme announced on August 1, 2024. The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics for the period.
| Metric | Value |
|---|---|
| Date of Purchase | August 22, 2024 |
| Number of Shares Purchased | 594,968 |
| Highest Price Paid per Share | 374.80 pence |
| Lowest Price Paid per Share | 371.60 pence |
| Volume Weighted Average Price | 372.4152 pence |
| Registered Share Capital Post-Transaction | 9,126,285,552 ordinary shares |
Material Changes
The primary material change reported is the reduction in the company's registered share capital following the cancellation of 594,968 ordinary shares purchased for cancellation. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing does not contain updated financial guidance, management commentary on future outlook, or new risk factors. It serves strictly as a regulatory disclosure of a share repurchase activity in compliance with the Market Abuse Regulation (EU) No 596/2014 as applied in the UK.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the August 1, 2024 Buyback Programme.
- Confirm the remaining authorized buyback amount and the programme's end date.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing for granular transaction data.
- Check subsequent filings for any further share repurchases or changes to the registered share capital.